Radon Therapy Boulder Montana
Radon Therapy Blog

Philadelphia Inquirer article on “Scientists study using low-dose radiation” – radon.gal@gmail.com – Gmail.

Response by Mohan Doss – used with permission:

Mohan Doss

Sep 9 (1 day ago)

to Patricia
Dear Pat,
FYI: Recently a reporter from our local newspaper Philadelphia Inquirer interviewed me over phone for about an hour talking about my work in the area of low dose radiation.   I was somewhat apprehensive about what may be in the article she was about to write, as I have observed sometimes that such articles in popular media have inaccuracies that detract from the story.Her article appeared yesterday in the newspaper with the title “Scientists study using low-dose radiation” available at the link: http://articles.philly.com/2013-09-08/news/41876116_1_radiation-exposure-low-dose-radiation-ionizing-radiation.  Though the article has a few technical inaccuracies in details, it is indeed correct in the overall message it conveys about the current state of the art in this area, in my opinion.  The conclusion of the article regarding low dose radiation is ambiguous and unclear because of dismissive statements of “experts”, not data.  Certainly the overall message is more realistic than the usual ones appearing in popular media about the risk of cancer from low dose radiation, e.g. from CT scans.  Hence, I am pleased with the article, though I would have phrased it somewhat differently.
With best regards,
Mohan–
Mohan Doss, Ph.D., MCCPM
Medical Physicist,
Associate Professor, Diagnostic Imaging,
Fox Chase Cancer Center, R427
333 Cottman Avenue,
Philadelphia, PA 19111-2497.
Phone: 215 214-1707
Fax:   215 728-4755
E-mail:  Mohan.Doss@fccc.edu

CONFIDENTIALITY NOTICE: This email communication may contain private, confidential, or legally privileged information intended for the sole use of the designated and/or duly authorized recipient(s). If you are not the intended recipient or have received this email in error, please notify the sender immediately by email and permanently delete all copies of this email including all attachments without reading them. If you are the intended recipient, secure the contents in a manner that conforms to all applicable state and/or federal requirements related to privacy and confidentiality of such information.

Scientists study using low-dose radiation – Philly.com.

POSTED: September 08, 2013

In very rare cases, using radiation to kill the primary tumor of a patient with metastatic cancer leads to the disappearance of tumors throughout the body.

Scientists can’t explain this amazing collateral effect, but it seems to activate an antitumor immune response.

Mohan Doss, a medical physicist at Fox Chase Cancer Center, believes the distant tumors melt away because of incidental low-dose rays emanating from the high-dose therapy. And that bolsters a theory he has researched for years: radiation at or slightly above natural background levels can stimulate the body’s disease-fighting defenses.

“When you have high-dose radiation, it suppresses the immune system,” he said. “Low doses actually enhance the immune system.”

Toxicologist says NAS panel ‘misled the world’ when adopting radiation exposure guidelines.

Aug. 13, 2013 — In two recently published peer-reviewed articles, toxicologist Edward Calabrese of the University of Massachusetts Amherst describes how regulators came to adopt the linear no threshold (LNT) dose-response approach to ionizing radiation exposure in the 1950s, which was later generalized to chemical carcinogen risk assessment.

Why Everything You Know About Cancer And The Environment Is Wrong – Forbes.

by Patrick Michaels, Forbes contributor – Aug. 8, 2013

Perseveration on global warming naturally inclines one to seek out other areas of  “science” where things aren’t exactly what they so obviously are, which brings me to the remarkable work of the most important toxicological scientist you have never heard of,   Dr. Ed Calabrese of the University of Massachusetts.

His work, painstaking and seemingly obscure, is upsetting just about everything we “know” about cancer and other illnesses commonly associated with environmental “pollutants.” If taken to its logical conclusion, it could derail much of Washington’s regulatory bureaucracy, particularly the EPA’s. Not that this is going to happen overnight, but as Calabrese’s work is increasingly accepted (as has been happening in recent years), the current regulatory paradigm will be forced to adjust.